Baynes Roy D. (CIK 1680739) reported 37 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-06-30). Recent activity: Buy NTRA (1,571 shares), Buy NTRA (75 shares), Buy TVTX (4,500 shares), Sell TVTX (4,500 shares), Buy TVTX (4,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-30 | Natera, Inc. (NTRA) | Director | Buy | 1,571 | $0 |
| 2026-06-30 | Natera, Inc. (NTRA) | Director | Buy | 75 | $0 |
| 2026-06-16 | Travere Therapeutics, Inc. (TVTX) | Director | Buy | 4,500 | $96,210 |
| 2026-06-16 | Travere Therapeutics, Inc. (TVTX) | Director | Sell | 4,500 | $225,000 |
| 2026-05-21 | Travere Therapeutics, Inc. (TVTX) | Director | Buy | 4,000 | $0 |
| 2026-04-28 | Natera, Inc. (NTRA) | Director | Buy | 83 | $0 |
| 2026-04-16 | Travere Therapeutics, Inc. (TVTX) | Director | Sell | 6,750 | $284,310 |
| 2026-04-16 | Travere Therapeutics, Inc. (TVTX) | Director | Buy | 9,000 | $138,870 |
| 2026-04-16 | Travere Therapeutics, Inc. (TVTX) | Director | Buy | 4,500 | $82,215 |
| 2026-04-16 | Travere Therapeutics, Inc. (TVTX) | Director | Buy | 4,500 | $96,210 |
| 2026-04-16 | Travere Therapeutics, Inc. (TVTX) | Director | Buy | 6,750 | $115,492 |
| 2026-04-16 | Travere Therapeutics, Inc. (TVTX) | Director | Sell | 26,000 | $1.1M |
| 2026-04-16 | Travere Therapeutics, Inc. (TVTX) | Director | Buy | 8,000 | $143,520 |
| 2026-04-07 | Travere Therapeutics, Inc. (TVTX) | Director | Buy | 10,000 | $265,200 |
| 2026-04-07 | Travere Therapeutics, Inc. (TVTX) | Director | Sell | 10,000 | $330,000 |
| 2026-02-03 | Natera, Inc. (NTRA) | Director | Buy | 70 | $0 |
| 2025-11-21 | Natera, Inc. (NTRA) | Director | Buy | 5,112 | $209,234 |
| 2025-11-21 | Natera, Inc. (NTRA) | Director | Sell | 1,250 | $266,838 |
| 2025-11-21 | Natera, Inc. (NTRA) | Director | Sell | 1,727 | $370,942 |
| 2025-11-21 | Natera, Inc. (NTRA) | Director | Sell | 2,135 | $461,309 |
| 2025-11-21 | Natera, Inc. (NTRA) | Director | Buy | 600 | $24,558 |
| 2025-11-21 | Natera, Inc. (NTRA) | Director | Buy | 7,068 | $291,131 |
| 2025-11-21 | Natera, Inc. (NTRA) | Director | Sell | 1,184 | $260,646 |
| 2025-11-21 | Natera, Inc. (NTRA) | Director | Sell | 900 | $199,629 |
| 2025-11-21 | Natera, Inc. (NTRA) | Director | Sell | 1,800 | $401,220 |
Source: SEC Form 4 filings · as of 2026-06-30